Medication info
Easy Simvastatin 10/20mg (Ezetimibe, Simvastatin)

Easy Simvastatin 10/20mg (Ezetimibe, Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Seohung Co., Ltd.
Appearance
Biconvex rectangular tablet, white to off-white
Packaging
30 tablets (10 tablets/Alu-Alu x 3)
Approval status
Active

MFDS item code 201007236 · Notified 2010.11.29 · Insurance code 679601020

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg to 10/40mg daily. The generally recommended starting dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Seohung Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases due to hypercholesterolemia
View approved original text

This medication is used as an adjunct to dietary therapy for reducing total cholesterol, LDL cholesterol, Apo B, and triglycerides in patients with primary hypercholesterolemia and mixed dyslipidemia while increasing HDL cholesterol. It is also used in conjunction with other treatments or on its own to lower elevated cholesterol levels in patients with homozygous familial hypercholesterolemia. This medication should be used together with an appropriate diet, and is recommended when non-pharmacological measures are insufficient. Before starting medication, it is necessary to identify other causes of dyslipidemia and treat them if needed. It should also be used with caution in patients at cardiovascular risk related to dyslipidemia, with regular monitoring of lipid levels. Consequently, it effectively improves total cholesterol and LDL cholesterol.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg to 10/40mg daily. The generally recommended starting dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication is used to lower blood cholesterol levels. Musculoskeletal side effects such as muscle pain or weakness can occur while taking this medication; if any unusual symptoms arise in the muscles, immediate consultation with a physician is required. The risk of muscle damage increases, especially at high doses, so caution is necessary. It can affect liver function and should not be administered to patients with liver disease or elevated liver function tests. Women who are pregnant or breastfeeding should not take this medication, and those planning to become pregnant should consult with their doctor. This medication may interact with certain antifungals, antibiotics, and antivirals, increasing the risk of side effects, so it is crucial to inform your doctor about any concomitant medications. Elderly patients or those with impaired kidney function should use it more cautiously, and regular blood tests are recommended to monitor liver function and muscle condition. If unexplained muscle pain, tenderness, or weakness persists during treatment, immediate consultation with healthcare professionals is necessary. Some medications should not be used in conjunction with this one, so be sure to inform healthcare personnel before starting any new medication. There is no specific antidote for overdose, so proper treatment should be sought immediately at a hospital.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 97 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver amino transferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • myasthenia
  • cataracts
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • ophthalmoplegia
  • facial paresis
  • tremors
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorders
  • anxiety
  • sleep disturbances
  • memory impairment
  • forgetfulness
  • amnesia
  • memory disorders
  • confusion
  • interstitial lung disease
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestatic jaundice
  • liver fat change
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in an airtight container to protect it from air and moisture, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain its effectiveness and prevent degradation.

Appearance and packaging

Appearance

Biconvex rectangular tablet, white to off-white

Package unit

30 tablets (10 tablets/Alu-Alu x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.